Pfizer: Metabolic Diseases trials

The registry lists 11 Metabolic Diseases studies with Pfizer as lead sponsor. 2 are open to participants now and 3 have results posted.

Phase 1 6Phase 2 1Phase 3 3No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or ObesityRecruitingNCT07874633Phase 3
• A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityRecruitingNCT07595549Phase 3
• A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)CompletedNCT04516291Phase 2Results posted
• A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With HypercholesterolemiaCompletedNCT01435382Phase 1Results posted
• Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult FemalesCompletedNCT01301456Phase 1Results posted
• A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)Active, not recruitingNCT07400653Phase 3
• A Multiple Oral Doses Study Of PF-06427878 In Healthy Adult SubjectsCompletedNCT02391623Phase 1
• A Single Oral Dose Study Of PF-06427878 In Healthy Adult SubjectsCompletedNCT02208284Phase 1
• A Multiple Dose Study Of PF-06678552 In Healthy SubjectsCompletedNCT02079922Phase 1
• A Single Dose Study Of PF-06678552 In Healthy SubjectsCompletedNCT01992614Phase 1
• Study Evaluating Metabolic Syndrome in Subjects Undergoing Gastric Bypass Bariatric SyndromeTerminatedNCT00283374